Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

8.3%

1 terminated/withdrawn out of 12 trials

Success Rate

87.5%

+1.0% vs industry average

Late-Stage Pipeline

8%

1 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 4
1(20.0%)
Phase 2
1(20.0%)
5Total
N/A(3)
Phase 4(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials
NCT07390669Not ApplicableActive Not Recruiting

OptimAIR: Towards Right Care in Asthma Through Point-of-care Phenotyping, Guideline-based Assessment and Management Optimalisation Using the AsthmaOptimiser in Primary Care

Role: lead

NCT07374172Active Not Recruiting

SADT in COPD and Oscillometry in Obstructive Airway Disease in Primary Care. The SCOOP-study

Role: lead

NCT07320703Not ApplicableRecruiting

"Breathlessness Diagnostics in a Box" (BiaB) for Primary Care. A Multi-country Quality Improvement Project Using a Randomized Stepped-wedge Design

Role: lead

NCT06659666Completed

The COPD Optimiser

Role: lead

NCT06398821Phase 2Completed

G3P-01 in Volunteers With Elevated Galectin-3

Role: lead

NCT05321095Completed

Screening for Albuminuria at the First Line for Early Identification of CKD

Role: lead

NCT04456270Completed

Asthma Control in a Dutch Primary Care Population

Role: lead

NCT06383130Not Yet Recruiting

London Asthma Diagnostics Study

Role: collaborator

NCT04539457Not ApplicableCompleted

Managing Appropriate Prescribing in COPD

Role: lead

NCT05162157Completed

Home Spirometry in Primary Care: an Implementation Study

Role: lead

NCT04532853Completed

Optimizing Maintenance Therapy in COPD Patients

Role: lead

NCT04746430Phase 4Terminated

COVID-19 Primary Care Platform for Early Treatment and Recovery (COPPER) Study

Role: lead

All 12 trials loaded